Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bixin Xi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Diabetes/Metabolism Research and Reviews|April 9, 2005
Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitorsJames Lester Figarola, Steven Scott, Sofia Loera, et al.
Chemical Research in Toxicology|September 24, 2008
Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometryTimothy Synold, Bixin Xi, Gerald E Wuenschell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6Min Guan, Kristen Fousek, Chunling Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2005
DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor geneAhmad Besaratinia, Timothy W Synold, Hsiu-Hua Chen, et al.
Molecular Cancer Therapeutics|May 21, 2010
Structural basis on the dityrosyl-diiron radical cluster and the functional differences of human ribonucleotide reductase small subunits hp53R2 and hRRM2Bingsen Zhou, Leila Su, Yate-Ching Yuan, et al.
Molecular Cancer Therapeutics|December 24, 2005
A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductasesBingsen Zhou, Jimin Shao, Leila Su, et al.
Free Radical Biology & Medicine|January 15, 2013
Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenograftsJames H Doroshow, Shikha Gaur, Susan Markel, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2012
Single-dose pharmacokinetic and toxicity analysis of pyrrole-imidazole polyamides in miceTimothy W Synold, Bixin Xi, Jun Wu, et al.
Journal of Hematology & Oncology|January 25, 2017
Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancerXiaoxue Zhang, Dan Liu, Mengchen Li, et al.
Cancer Chemotherapy and Pharmacology|September 18, 2012
Phase I study of nelfinavir in liposarcomaJanet Pan, Michelle Mott, Bixin Xi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Diabetes/Metabolism Research and Reviews|April 9, 2005
Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitorsJames Lester Figarola, Steven Scott, Sofia Loera, et al.
Chemical Research in Toxicology|September 24, 2008
Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometryTimothy Synold, Bixin Xi, Gerald E Wuenschell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6Min Guan, Kristen Fousek, Chunling Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2005
DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor geneAhmad Besaratinia, Timothy W Synold, Hsiu-Hua Chen, et al.
Molecular Cancer Therapeutics|May 21, 2010
Structural basis on the dityrosyl-diiron radical cluster and the functional differences of human ribonucleotide reductase small subunits hp53R2 and hRRM2Bingsen Zhou, Leila Su, Yate-Ching Yuan, et al.
Molecular Cancer Therapeutics|December 24, 2005
A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductasesBingsen Zhou, Jimin Shao, Leila Su, et al.
Free Radical Biology & Medicine|January 15, 2013
Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenograftsJames H Doroshow, Shikha Gaur, Susan Markel, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2012
Single-dose pharmacokinetic and toxicity analysis of pyrrole-imidazole polyamides in miceTimothy W Synold, Bixin Xi, Jun Wu, et al.
Journal of Hematology & Oncology|January 25, 2017
Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancerXiaoxue Zhang, Dan Liu, Mengchen Li, et al.
Cancer Chemotherapy and Pharmacology|September 18, 2012
Phase I study of nelfinavir in liposarcomaJanet Pan, Michelle Mott, Bixin Xi, et al.
Pageof 3